CAS 41552-82-3: N6-cyclopentyladenosine
Formula:C15H21N5O4
InChI:InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1
InChI key:InChIKey=SQMWSBKSHWARHU-SDBHATRESA-N
SMILES:O[C@H]1[C@H](N2C=3C(N=C2)=C(NC4CCCC4)N=CN3)O[C@H](CO)[C@H]1O
Synonyms:- (2R,3R,4S,5R)-2-[6-(Cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- Adenosine, N-cyclopentyl-
- N(6)-Cyclopentyladenosine
- N-cyclopentyl-9-pentofuranosyl-9H-purin-6-amine
- N-cyclopentyladenosine
- N<sup>6</sup>-Cyclopentyladenosine
- Uk 80882
- N6-Cyclopentyladenosine
- N6-cyclopentyladenosine
- CPA
Sort by
Found 6 products.
N6-Cyclopentyladenosine
CAS:Controlled ProductFormula:C15H21N5O4Color and Shape:NeatMolecular weight:335.358N6-Cyclopentyladenosine
CAS:N6-Cyclopentyladenosine (CPA) is a selective agonist of the adenosine A1 receptor and can be used to mimic the action of the adenosine A1 receptor, with Ki's ofFormula:C15H21N5O4Purity:99.84%Color and Shape:SolidMolecular weight:335.36N6-Cyclopentyladenosine
CAS:N6-Cyclopentyladenosine is a nucleoside analog that binds to the kappa-opioid receptor. The physiological effects of this drug are mediated through its interaction with the kappa-opioid receptor, which is found in the central nervous system and mediates many of the effects of morphine. N6-Cyclopentyladenosine has been shown to increase blood flow and heart rate in humans. This drug also inhibits tetrazolium dye uptake by papillary muscle cells, suggesting that it may have cardiotonic effects. N6-Cyclopentyladenosine has been used as an analytical probe for adenosine, which is metabolized by cyclic AMP and cyclic GMP phosphodiesterases into adenosine 3',5'-cyclic monophosphate (cAMP).Formula:C15H21N5O4Purity:Min. 95%Color and Shape:PowderMolecular weight:335.36 g/molN6-Cyclopentyladenosine
CAS:Formula:C15H21N5O4Purity:≥ 99.0%Color and Shape:White to off-white powderMolecular weight:335.36
